Ketone body metabolism

Last updated: November 01, 2022

Ketone body metabolism

HMBP

HMBP

Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
DNA replication
DNA damage and repair
Cell cycle
DNA mutations
Cellular structure and function
Introduction to pharmacology
Enzyme function
Pharmacodynamics: Agonist, partial agonist and antagonist
Human development days 1-4
Human development week 2
Human development days 4-7
Human development week 3
Ectoderm
Mesoderm
Endoderm
Ionic bonding
Covalent bonding
Physiologic pH and buffers
Buffering and Henderson-Hasselbalch equation
Acid-base disturbances: Pathology review
Electron transport chain and oxidative phosphorylation
Glycogen metabolism
Pentose phosphate pathway
Gluconeogenesis
Cell membrane
Cytoskeleton and intracellular motility
Selective permeability of the cell membrane
Cell signaling pathways
Mitosis and meiosis
Light microscopy and staining methods
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Arsenic poisoning
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Independent assortment of genes and linkage
Inheritance patterns
Drug administration and dosing regimens
Cholesterol metabolism
Ketone body metabolism
Fatty acid synthesis
Nitrogen and urea cycle
Amino acid metabolism
Protein structure and synthesis
Nucleotide metabolism
Gout
Gout and pseudogout: Pathology review
Severe combined immunodeficiency
Fatty acid oxidation
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
Gel electrophoresis and genetic testing
Karyotyping
Fluorescence in situ hybridization
Citric acid cycle
Glycolysis
Carbohydrates and sugars
Cystinosis
Friedreich ataxia
Achondroplasia
Niemann-Pick disease type C
Gaucher disease (NORD)
Fabry disease (NORD)
Niemann-Pick disease types A and B (NORD)
Krabbe disease
Adrenoleukodystrophy (NORD)
Fragile X syndrome
Cystinuria (NORD)
Hartnup disease
Lesch-Nyhan syndrome
Rett syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Myasthenia gravis
Charcot-Marie-Tooth disease
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Tay-Sachs disease (NORD)
Cystic fibrosis
Williams syndrome
Cri du chat syndrome
Angelman syndrome
Prader-Willi syndrome
Turner syndrome
Patau syndrome (Trisomy 13)
Edwards syndrome (Trisomy 18)
Down syndrome (Trisomy 21)
Fanconi anemia
Xeroderma pigmentosum
Osteogenesis imperfecta
Marfan syndrome
Ehlers-Danlos syndrome
Primary ciliary dyskinesia
Disorders of carbohydrate metabolism: Pathology review
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Glycogen storage disease type IV
Glycogen storage disease type V
Glycogen storage disease type III
Glycogen storage disease type I
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Galactosemia
Essential fructosuria
Pyruvate dehydrogenase deficiency
Hereditary fructose intolerance
Proteins

Transcript

Watch video only

In life, it’s helpful to have a plan B in case plan A doesn’t work out.

In terms of energy, the body’s plan A is to generate energy from carbohydrates, fats, and proteins - basically in that order.

But if these main fuels aren’t readily available, then plan B is to use an alternative fuel source - ketone bodies.

Ketone bodies are a group of carbon-containing molecules produced by liver mitochondria using a 2-carbon molecule called acetyl-CoA.

The liver makes ketone bodies in physiologic states like prolonged fasting or exercise, as well as in pathological states like type 1 diabetes mellitus or alcoholism.

Ketone bodies can be released into the circulation and get picked up by the majority of cells.

Inside the cells, they’re reconverted back into acetyl-CoA, at which point they can then enter the mitochondria and produce ATP.

The 3 primary ketone bodies are acetoacetate, beta-hydroxybutyrate, and acetone.

Alright, so let’s say you decide to go on a 5-day fast.

About 12 hours into your fast, your blood glucose levels start to dip.

In response, glucagon is secreted from the pancreas and stimulates hepatic glycogenolysis - meaning that the liver begins to break down glycogen into glucose and release that glucose into the blood.

About 24 hours into your fast, your liver begins running out of glycogen, so it starts the process of gluconeogenesis which is where it makes new glucose molecules from substrates like amino acids.

Then, around 1 to 3 days into your fast, your body begins to run out of the necessary substrates to make new glucose.

So, it switches to breaking down fatty acids for energy.

Fatty acids are mobilized from fat stores and are broken down to acetyl CoA through beta oxidation in the mitochondria of most cells - except for brain cells.

See, thing is, fatty acids can’t cross the blood-brain barrier, so brain cells can only use glucose for energy - or, when there’s no glucose they use ketone bodies.

This makes sense from the liver’s standpoint as well because normally, acetyl-CoA combines with oxaloacetate in the citric acid cycle to make citrate.

But since oxaloacetate is also a substrate for gluconeogenesis, so it’s levels are pretty depleted at this point in starvation.

So oxaloacetate basically leaves all that acetyl-CoA hanging out by itself. Not cool oxaloacetate, not cool.

This means that the liver is practically overflowing with acetyl-CoA, and the liver converts it into ketone bodies, that various cells in our body, including the brain cells, can use.

Ketone body synthesis begins with 2 acetyl-CoA molecules getting joined together by the enzyme acetyl-CoA acyl-transferase.

The result is a 4-carbon molecule called acetoacetyl-CoA and then a free CoA molecule.

Next, the enzyme HMG-CoA synthase combines acetoacetyl-CoA and acetyl-CoA to form a 6-carbon molecule called 3-hydroxy-3-methylglutaryl CoA, or HMG-CoA - so 3 acetyls and then a free CoA molecule.

Key Takeaways

Ketone bodies like beta-hydroxybutyrate and acetoacetate are an alternative source of energy in states of prolonged starvation. Ketone body synthesis occurs in the liver in physiologic states like prolonged fasting or exercise, as well as in pathological states like type 1 diabetes mellitus or alcoholism. Once synthesized, ketone bodies can leave the liver, and enter into peripheral cells such as the brain, skeletal muscle and kidney to serve as energy sources.